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Background: Nuclear reprogramming is potentially important as a route to cell replacement and drug discovery,
but little is known about its mechanism. Nuclear transfer to eggs and oocytes attempts to identify the mechanism
of this direct route towards reprogramming by natural components. Here we analyze how the reprogramming of
nuclei transplanted to Xenopus oocytes exploits the incorporation of the histone variant H3.3.
Results: After nuclear transplantation, oocyte-derived H3.3 but not H3.2, is deposited on several regions of the
genome including rDNA, major satellite repeats, and the regulatory regions of Oct4. This major H3.3 deposition
occurs in absence of DNA replication, and is HIRA-and transcription-dependent. It is necessary for the shift from a
somatic- to an oocyte-type of transcription after nuclear transfer.
Conclusions: This study demonstrates that the incorporation of histone H3.3 is an early and necessary step in the
direct reprogramming of somatic cell nuclei by oocyte. It suggests that the incorporation of histone H3.3 is
necessary during global changes in transcription that accompany changes in cell fate.Background
Nuclear reprogramming is characterized by a global shift
in gene expression. The mechanisms underlying this
phenomenon are not well understood but are likely to
involve changes to chromatin. For example, an increase
in histone H3K4 methylation has been observed in
nuclei following nuclear transfer (NT) and during iPS
production [1,2]. Alternatively, the incorporation of
histone variants into chromatin can provide another way
to drastically alter the structure of chromatin. Nucleo-
somes containing core histone variants H3.3 or macroH2A
have been associated with the active and inactive states of
a gene, respectively. MacroH2A restricts the reactivation
of pluripotency genes from mouse nuclei transplanted to
Xenopus oocytes [3]. In nuclear transfer to Xenopus eggs,
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reproduction in any medium, provided the orstate of a gene, even in embryonic lineages where genes
should be silenced [4]. Furthermore, histone variants
are also positively involved in the mechanism of tran-
scriptional reprogramming. We have previously shown
that the incorporation of histone B4, an oocyte specific
linker histone variant, is a necessary step for nuclear re-
programming following nuclear transfer [5]. A number
of histone changes are already known to be associated
with nuclear reprogramming by eggs and oocytes. While
those observed in eggs may well be related to DNA
synthesis and cell replication coupled events during the
cell cycle, those that take place in somatic nuclei trans-
planted to oocytes which do not replicate DNA and are
arrested in prophase I of meiosis are associated essen-
tially with new transcription and are independent of cell
cycle progression.
Here we investigate the dynamics of histone H3 variants
in the reprogramming of mammalian nuclei transplanted
to Xenopus oocytes. In this type of reprogramming there
is no cell division and new cell types are not derived.
However, the transplanted nuclei undergo dramatic
changes in their pattern of gene expression so thatLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cyte type. The evolutionarily conserved histone variant
H3.3 has been found to be especially enriched in the cod-
ing region of transcriptionally active genes as well as in
gene regulatory elements [6]. This histone is often asso-
ciated with histone modifications related to gene activation
[7,8]. Histone H3.3 can be incorporated into chromatin
throughout the cell cycle in a replication independent
manner by the histone chaperone HIRA [9,10], which is
also found to be required for global H3.3 deposition in the
male pronucleus after fertilization in Drosophila [11]. This
association between histone H3.3 and the HIRA depos-
ition pathway has been further demonstrated to play a
critical role during a major change in gene expression at
gastrulation in Xenopus [12]. Finally, early work showed
that plasmid DNA injected to oocytes is differently tran-
scribed depending on whether its chromatin has been
assembled in a DNA synthesis dependent or independent
manner [13]. Together these findings prompted us to
investigate the importance of the histone variant H3.3 and
its deposition in transcriptional reprogramming of nuclei
transplanted to Xenopus oocytes. We demonstrate that the
deposition of H3.3 by HIRA is necessary for transcriptional
reprogramming. We also observe that HIRA mediated
H3.3 deposition and transcription are interdependent in
somatic nuclei transplanted to Xenopus oocytes.Results and discussion
Gain and loss of histone H3 variants
In order to investigate the mechanism of transcriptional
reprogramming by oocytes, we have first monitored the
transfer of histone variants between the oocyte and the
transplanted nuclei. We have focused our analysis on
histone H3.2 and H3.3, the two non-centromeric histone
H3 variants known to be present in Xenopus. Triton
Acetic acid Urea (TAU) gel analysis indicates that in the
Xenopus oocyte, the ratio of histone H3.3 to that of his-
tone H3.2 is much higher than in somatic cells
(Figure 1A). Indeed TAU gel analysis shows that cells of
Stage 28 Xenopus embryo contain approximately five
times less H3.3 than H3.2, whereas the Xenopus oocyte
germinal vesicle (GV) exhibits a two-fold excess of H3.3
over H3.2. Thus, the Xenopus oocyte GV is character-
ized by an unusually high proportion of histone H3.3
variant. We have asked whether core histone variants
originating from the oocyte can be deposited onto the
chromatin of transplanted nuclei. For that purpose we
have expressed in the oocyte, by mRNA injection, fluor-
escently tagged histone H3.2 and H3.3 (Figure 1B).
Forty-eight hours after mRNA injection, tagged histones
are expressed in the oocyte at a similar level to their en-
dogenous counterparts (Additional file 1: Figure S1 and
Figure 1A). ES nuclei expressing H3.2-cherry are thentransplanted into these oocytes, and incubated for an-
other day, when their germinal vesicles containing trans-
planted nuclei were isolated and analyzed by confocal
microscopy (Figure 1C). H3.2-cherry marks the
location of donor nuclei and 48 h after nuclear transfer,
we observe an accumulation of oocyte H3.3 in trans-
planted chromatin an effect not seen with oocyte H3.2
(Figure 1C). At 48 h after nuclear transfer, most of the
nuclei have lost nuclear membrane integrity indicating
that the observed accumulation of H3.3 corresponds to
its incorporation onto transplanted chromatin rather
than nuclear import. When monitored by confocal ana-
lysis in real time, the incorporation of oocyte H3.3 onto
transplanted chromatin is readily detectable 10 h after
nuclear transfer. H3.3 incorporation steadily increases
and is observed in all transplanted nuclei 15 h after
nuclear transplantation (Additional file 1: Figure S2,
oocyte H3.3). We conclude from these experiments that
following nuclear transfer to Xenopus oocytes, a high
incorporation of H3.3 compared to H3.2, is observed in
transplanted chromatin.
We have then asked whether the loading of oocyte
H3.3 onto transplanted chromatin is associated with
the loss of H3.2 or H3.3 from donor nuclei. For that
purpose we have used donor nuclei containing cherry
labeled H3.2 or H3.3. Quantitation of the level of
cherry labeled histones that remain associated with
donor nuclei after transplantation to oocytes was done
by confocal microscopy. We observed that during the
first 12 h after nuclear transfer 15% and 19% of
H3.2-cherry or H3.3-cherry, respectively, are lost from
transplanted nuclei (Figure 1D). This suggests that
following nuclear transfer to Xenopus oocytes, a sig-
nificant fraction of H3.2 and H3.3 in donor nuclei is
replaced by oocyte H3.3. The mobility of core his-
tones on the chromatin of nuclei transplanted to Xen-
opus oocytes is not known. Changes in histone
mobility have been proposed to account for plasticity
in transcription [14] and could therefore account for
the change in gene expression observed after nuclear
transfer. We therefore investigated whether
histone H3.3 incorporated after transplantation corre-
sponds to a fraction of the transplanted nuclear core
histone that has become highly mobile. When tested
by FRAP analysis over a period of 20 min, we
observed that oocyte derived H3.3 loaded onto trans-
planted chromatin does not recover above the level of
H3.3 found in the surrounding germinal vesicle
(Figure 1E). By contrast oocyte derived HP1-alpha
fully recovers within the 20 min following photo
bleaching, indicating that within the imaging condi-
tions used some chromatin associated protein exhibits
rapid turnover. We therefore conclude that, once
incorporated into transplanted nuclei, the newly
Figure 1 (See legend on next page.)
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Figure 1 H3.3 but not H3.2 is accumulated in transplanted nuclei. (A) H3.2 vs. H3.3 content in oocyte GVs, eggs, and st28 embryos. Soluble
pool of H3.2 and H3.3 were separated by Triton Acid Urea (TAU) gel electrophoresis and analyzed by western blot with an anti-H3 antibody.
We loaded the equivalent of 20 and 10 GV, and about two eggs or st28 embryos. (B) Schematic outline of injection procedure, where mRNAs
coding for tagged Xenopus histones are injected into oocyte cytoplasm 1 day before injection of donor nuclei. Oocytes containing transplanted
nuclei are then incubated for 1 to 2 days and submitted to either live imaging, ChIP, or qRT-PCR analysis. (C) H3.2-cherry labelled ESC nuclei
were transplanted to the germinal vesicle of H3.2-GFP or H3.3-GFP containing oocytes. Forty-eight hours after transplantation germinal vesicles
were isolated and analyzed by confocal microscopy. Images are projection of Z-stack. (D) Quantification of H3.3-Cherry or H3.2-Cherry loss
from transplanted nuclei. Donor ESC nuclei expressing H3.3-Cherry or H3.2-Cherry were transplanted to GVs isolated in oil and were imaged
immediately (0 h) or 12 h after transplantation. The histogram shows fluorescently labeled histone signal averaged from 40 nuclei in each
condition (Error bars indicate s.e.m). ★ indicate P value < 0.05, (T-TEST). (E) FRAP analysis of oocyte H3.3 and HP1alpha associated with
transplanted nuclei. ESC nuclei were transplanted to H3.3-Cherry and GFP-HP1-alpha expressing oocytes. Forty-eight hours after transplantation,
GVs were isolated and H3.3-cherry and GFP-HP1alpha accumulated on transplanted chromatin was subjected to FRAP analysis. Images show a
clump of labeled nuclei at various time points during the FRAP procedure. The graph indicates fluorescence intensity changes over time for
the tested chromatin region as well as in the surrounding GVplasm. Fluorescence intensity of H3.3 Cherry on transplanted chromatin at the
beginning of the experiment is set to 1. Note that H3.3 Cherry fluorescence intensity in the GVplasm amounts to about 40% of H3.3-Cherry
accumulated on chromatin, and remains constant during the course of the FRAP experiment.
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planted nuclei incorporate H3.3 readily from the oo-
cyte, thereby changing their chromatin landscape and
possibly reprogramming transcription.
Timing of H3.3 incorporation and transcription
We have investigated how the association of histone
H3.3 with transplanted nuclei relates to transcrip-
tional reprogramming. Work in cultured cells has
shown that H3.3 is present in specific parts of the
genome. It is enriched in heterochromatic regions
such as telomeres [6] and satellite repeats found at
pericentric chromatin [15], as well as on ribosomal
genes [16]. Lastly, H3.3 is accumulated on transcrip-
tion factor binding sites in the regulatory regions of
most genes as well as on the coding regions of tran-
scribed genes in cultured mouse ES cells [6], and in
cultured human HeLa cells [17]. We have therefore
focused our analysis of H3.3 binding
following nuclear transfer specifically to parts of the
genome that reflect genomic H3.3 distribution in the
cultured cells. We have thus monitored rDNA 28S
genes (100 copies per genome) and major satellite
repeats (approximately 3% of the mouse genome)
[18]. Additionally, we have established a mouse em-
bryonic cell line containing an array of approxi-
mately 20 copies of the 3.6 kB regulatory region of
the Oct4 promoter fused to the coding region of
neomycin resistance as reporter, here called ESC #5
(Figure 2A). Using that array we can monitor, by
ChIP analysis, histone variant binding to a reporter
gene. Induction of differentiation by retinoic acid
(RA) treatment of ES cells is known to repress pluri-
potency gene transcription and to specifically invoke
epigenetic changes resembling those of silent hetero-
chromatin over the Oct4 gene [19], and we have
taken advantage of this system to analyze silent
chromatin reactivation after NT.By qRT-PCR we have confirmed that 4-day ret-
inoic acid (RA) treatment of the reporter ES cell line
ESC#5 (RA-ESC#5) induces silencing of the endogenous
pluripotency genes Sox2 and Oct4 as well as of the Oct4
transgene (Additional file 1: Figure S3). To confirm that
the oocyte successfully reactivates the Oct4 transgene,
a transcription analysis was carried out with RA-ESC
#5 nuclei carrying the silent Oct4 array analyzed at
various times after NT. We observe transcription of
the rDNA 28S, major satellite repeat, as well as the
previously silent Oct4 reporter within 12 to 20 h after
nuclear transfer (Figure 2B). The level of all three
kinds of transcript is greatly increased from 20 h to
48 h after transplantation. In particular, we note that
transcripts from the rDNA and major satellite regions
are accumulated to levels that largely exceed those
observed in the donor nuclei immediately after nu-
clear transfer (at least 20-fold, Figure 2B, compare
0 h and 48 h after transplantation). The observed in-
crease in rRNA and major satellite transcripts after
nuclear transfer suggests transcriptional reprogram-
ming of these parts of the genome too. However
since both rDNA and pericentric heterochromatin can
be transcribed in cultured cells, the observed accumu-
lation of transcripts from these regions following nu-
clear transfer (Figure 2B) could result from a somatic
type of transcription associated with increased tran-
script stability in the oocyte.
To confirm transcriptional reprogramming of these
genomic regions we have directly measured whether
their rate of transcription from transplanted nuclei
changes after nuclear transfer. In order to measure
changes in rate of transcription we have labeled new
transcripts produced from transplanted nuclei by inject-
ing BrUTP into the oocyte (Figure 2C). BrUTP was
injected at different times after nuclear transfer and
oocytes collected 12 h after injection. In that way the
transcripts are labeled with BrUTP for 12-h periods
Figure 2 Kinetics of transcription and H3.3 incorporation following nuclear transplantation to Xenopus oocytes. (A) Schematic
representation of the Oct4 transgene composed of a 20 copy array in the embryonic stem cells used in this study (ESC #5). DE, Distal enhancer;
PE, Proximal enhancer; PP, Proximal promoter. (B) qRT-PCR analysis of transcription during a 48-h period following nuclear transplantation of
4 day-retinoic acid differentiated ESC #5 nuclei. Error bars indicate s.e.m. (n = 3). (C) Analysis of rDNA and major satellite transcription rates.
Oocytes were transplanted with RA-ESCs and injected with BrUTP at various times after nuclear transfer (at 0, 12, 24, or 36 h). Oocytes were then
collected 12 h after the time of BrUTP injection. In that way, the different samples collected will contain transcripts produced by the transplanted
nuclei and labeled by BrUTP during a 12-h period (T12 to 24 h, T24 to 36 h, T36 to 48 h). After mRNA extraction BrUTP labeled transcripts are
purified by immunoprecipitation with an anti-BrdUTP antibody and analyzed by qRT-PCR. Error bars indicate s.e.m. (n = 3). (D) ChIP analysis of
histone incorporation 24 h after NT in oocytes preinjected with mRNA for HA-H3.3 and HA-H3.2, performed over the Oct4 reporter promoter,
major satellite and ribosomal DNA genes, respectively. The total amount of incorporated H3.3 is set to 1. Error bars indicate standard deviation
(n = 3). (E) Analysis of histone incorporation kinetics over Oct4 regulatory regions after NT. Four-day retinoic acid treated ESC #5 were transplanted
in oocytes preinjected with mRNA for HA-H3.3 and HA-H3.2, collected over a 48-h time course and analyzed by ChIP with an HA antibody.
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beled transcripts are then immunoprecipitated with an
anti-BrdUTP antibody and analyzed by qRT-PCR, pro-
viding a measurement of transcript production per 12-h
period. We observe that the rate of transcription fromrDNA and major satellites increases approximately five
times between the 12 to 24 h and 24 to 36 h periods
that follow nuclear transplantation (Figure 2C). There-
fore the reprogramming of transplanted nuclei to an oo-
cyte type of transcription includes reactivation of silent
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rDNA and pericentric chromatin. We point out that
transcription of the latter has been observed in several
instances, especially at the time of early embryonic de-
velopment when heterochromatin is established [15,20].
We then compared the extent of the oocyte-expressed
H3.3 and H3.2 incorporation into the transplanted chro-
matin analyzing different regions of the transplanted
nuclei. For this purpose we expressed in the oocyte
HA tagged H3.3 or H3.2 prior to nuclear transfer.
The level of HA-H3 and HA-H3.3 obtained by mRNA
injection is similar to that of their endogenous counter-
part stored in the oocyte (Additional file 1: Figure S1
and Figure 1A). At 24 h after nuclear transfer of RA-
ESC #5, the oocytes were cross-linked and analyzed by
ChIP with an antibody recognizing the HA-tag in order
to determine the extent of incorporation of histones
from the oocyte. We found that HA-H3.3 was incorpo-
rated with an approximately 8-10-fold higher efficiency
compared to the background level of HA-H3.2, not only
over the Oct4 promoter but also over the major satel-
lite region and ribosomal DNA (Figure 2D). Therefore
the incorporation of oocyte H3.3 as opposed to H3.2
into transplanted nuclear chromatin as seen by immuno-
fluorescence analysis (Figure 1C) is also observed
by ChIP analysis. We conclude that H3.3 but not H3.2
is preferentially deposited on transplanted nuclear chro-
matin including regulatory regions such as in the
Oct4 promoter.
Our results so far indicate that H3.3 deposition is an
early event following NT but do not show whether it
precedes or follows the switch from somatic type to oo-
cyte type transcription. To address this we focused on
Oct4 reactivation and investigated the time at which
various parts of the Oct4 regulatory region exhibit his-
tone H3.3 incorporation. The oocytes were injected with
mRNA encoding HA-H3.3 as before and the next day
RA ESC #5 nuclei were used for NT. The oocytes were
then incubated and cross-linked at indicated time points
prior to ChIP analysis for the well conserved proximal
promoter (PP), proximal enhancer (PE), and the distal
enhancer (DE) of Oct4. We found that histone H3.3
incorporation increased greatly during the first 20 h
and then reached a plateau around 24 h after NT
(Figure 2E). No difference in the extent of H3.3 incorp-
oration between the promoter and enhancers was seen
for up to 72 h, indicating a uniform exchange over
the entire regulatory region of Oct4 after NT. At 20 h
after nuclear transfer, both gene reactivation (qRT-PCR,
Figure 2B) and H3.3 incorporation can be detected
(ChIP, Figure 2E). However, whereas H3.3 incorporation
on Oct4 regulatory regions reaches a maximum level
around 24 h after nuclear transfer (Figure 2E), the quan-
tity of accumulated Oct4 transcript increases massivelyafter that time (Figure 2B). This observation is consistent
with the hypothesis whereby H3.3 is incorporated onto a
gene (and reach a maximum plateau level) while enab-
ling activation and subsequent continuous accumulation
of the transcribed mRNAs.
H3.3 incorporation requires HIRA
We have next investigated whether H3.3 deposition on
transplanted nuclei is a pre-requirement or a conse-
quence of transcriptional reprogramming. We have first
asked whether HIRA, known to be required for H3.3
incorporation into the paternal genome after fertilization
[11] is also required for H3.3 deposition on nuclei fol-
lowing transplantation into the Xenopus oocyte. Recent
studies describe a HIRA dependency for genome-wide
H3.3 enrichment over transcribed regions of active genes
in mouse ES or human HeLa cells [6,17]. However this
incorporation of H3.3 seems not to be required for the
maintenance of ongoing transcription in the ESCs [6,17].
HIRA dependent H3.3 deposition in transplanted nuclei
was analyzed using a protein knockdown approach pre-
viously described and based on the co-injection of poly-
clonal antibodies together with the donor nuclei [5,21].
We used a polyclonal antibody that recognizes Xenopus
HIRA and that has been previously used to immunode-
plete HIRA protein from egg extract [9]. We verified
that this antibody, when injected to the oocyte, was effi-
ciently affecting DNA synthesis-independent chromatin
assembly on plasmid DNA (Additional file 1: Figure S4).
Oocytes expressing either HA-H3.3 or HA-H3.2 were
then used as recipients for nuclear transfer. Retinoic
acid-differentiated reporter ES cell nuclei were trans-
planted into oocytes, with the co-injection of an anti-
HIRA antibody (to inhibit HIRA) or alpha-amanitin (to
inhibit transcription). Twenty-four hours after nuclear
transfer the oocytes were analyzed by ChIP and qRT-
PCR. We observed that upon anti HIRA antibody injec-
tion, the deposition of maternally expressed HA-H3.3 on
the Oct4 regulatory regions, rDNA, and major satellite
repeats of the transplanted nuclei is reduced (Figure 3A,
compare lane 2 with lane 4). This indicates that HIRA
promotes histone H3.3 incorporation over the genomic
region that we have analyzed in the transplanted nuclei.
Interestingly when HIRA mediated H3.3 deposition is
inhibited an increased deposition of H3.2 is observed
(Figure 3A, compare lane 5 with lane 7). In the presence
of alpha-amanitin, neither H3.3 nor H3.2 is deposited
onto transplanted chromatin (Figure 3A). We conclude
that following nuclear transfer, H3.3 deposition on the
tested genomic region is a HIRA- and transcription-
dependent process. We have conducted a complemen-
tary analysis of H3.3 loading, this time on a global level,
by monitoring H3.3-GFP accumulation onto trans-
planted chromatin by confocal microscopy. Similar to
Figure 3 (See legend on next page.)
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Figure 3 A HIRA- and transcription- dependent H3.3 incorporation onto transplanted chromatin is required for transcriptional
reprogramming following nuclear transfer. (A) ChIP analysis of H3.2 and H3.3 incorporation onto transplanted chromatin following nuclear
transfer to oocytes under conditions where transcription or HIRA is inhibited. Recipient oocytes were preinjected with either no mRNA, HA-H3.2
mRNA, or HA-H3.3 mRNA. RA-ESC #5 nuclei were then injected in the GV with or without co-injection of either alpha amanitin (RNA Polymerase II
inhibition) or anti-HIRA Antibody (HIRA inhibition). Twenty-four hours after transplantation H3.2 and H3.3 incorporation onto various genomic
regions was measured by ChIP analysis. Error bars indicate s.e.m. (n = 3). (B) Confocal analysis of H3.3 accumulation onto transplanted chromatin
following nuclear transfer to oocytes in conditions where transcription or HIRA is inhibited. Oocytes were preinjected with H3.3-GFP mRNA. H3.2-
cherry expressing ESC #5 nuclei were then transplanted to the oocyte in the presence of either alpha amanitin (RNA Polymerase II inhibition),
anti-HIRA Antibody (HIRA inhibition), or control Antibody. Forty-eight hours after transplantation, H3.3-GFP loading onto chromatin was analyzed
by confocal imaging of isolated GVs. Graphs show fluorescence intensity of donor H3.2-cherry (red) and oocyte H3.3-GFP (green) across a section
of the image (black arrow). (C) qRT-PCR analysis of transcription 24 h following nuclear transfer of RA-ESC #5 nuclei in the presence of either
alpha amanitin (RNA Polymerase II inhibition), anti-HIRA Antibody (HIRA inhibition), or control Antibody. Error bars indicate s.e.m. (n = 3). (D)
Western blot analysis of xenopus HIRA expression 48 h following injection of HIRA mRNA to the oocytes. (E) qRT-PCR analysis of transcription
24 h following the transfer of RA-ESC #5 nuclei in the presence or absence of anti-HIRA antibody in GVs of oocytes pre-injected with
various doses of HIRA mRNA. Error bars indicate s.e.m. (n = 3). ★ indicate P value < 0.05, (T-TEST).
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inhibited by both anti-HIRA antibody and alpha-
amanitin injection (Figure 3B).
Together these data demonstrate that H3.3 depo-
sition on a global nuclear level is HIRA- and largely
transcription-dependent.
The alternative deposition of H3.2 in response to anti-
HIRA injection is also observed on a global nuclear
level when monitored by confocal microscopy, albeit on
a subset of transplanted nuclei only (Additional file 1:
Figure S5). This heterogeneous behavior of transplanted
nuclei might reflect the various phases of the cell cycle
that are represented in the donor nuclei population. Fur-
ther investigations will be needed to describe the mech-
anism by which HIRA inhibition following nuclear
transfer to Xenopus oocytes leads to H3.2 incorporation.H3.3 incorporation and transcription are interdependent
We next ask whether HIRA mediated H3.3 deposition is
required for transcriptional reprogramming. Inhibition
of HIRA by antibody injection greatly impairs transcrip-
tional reprogramming as shown by the reduced expres-
sion of Oct4 reporter, rDNA, and major satellite from
transplanted nuclei (qRT-PCR analysis, Figure 3C). Over-
expression of HIRA by mRNA injection into oocytes
prior to anti-HIRA antibody injection and nuclear trans-
fer partially rescues the effect of antibody injection
(Figure 3D and E). This observation confirms that
the antibody effect is through inhibition of HIRA. We
conclude that HIRA is required for the reprogram-
ming from a somatic to an oocyte type of transcription.
The alternative H3.2 deposition observed when HIRA
is inhibited (Figure 3A) is not sufficient to promote
transcriptional reprogramming (Figure 3C). This indi-
cates that a specific deposition of H3.3 is required for
efficient reprogramming.Conclusion
From a mechanistic point of view the requirement for
H3.3 is mediated by HIRA. H3.3 incorporation and tran-
scription seem to act in a cooperative and interdepend-
ent way. In cultured cells, inhibition of HIRA does not
interfere with transcription [6]. However in the context
of the developing embryo, HIRA activity is necessary at
gastrulation where cell lineages are determined [12]. To-
gether with these findings, our results reveal an
involvement of this histone chaperone in the genome
wide remodeling of transcription associated with major
transition between cell states. Importantly, physical
interactions between HIRA and the transcription ma-
chinery has recently been observed [17]. A requirement
for H3.3 deposition in the reprogramming of somatic
nuclei to an oocyte type of transcription may depend on
an interaction between RNA polymerase II and HIRA.
Methods
Nuclear transfer procedure
Nuclei preparation, live confocal imaging, and ChIP
analysis of transplanted nuclei have been previously
described [5,22,23].
TAU gel analysis
We prepared germinal vesicles (GV) soluble extracts
[24], and soluble fractions from eggs and stage 28
embryos using the High Speed Egg (HSE) extract proto-
col [25]. We analyzed those extracts by electrophoresis
in a Triton Acetic acid Urea (TAU) gel that separates
histone subtypes [26].
Antibodies
We used the following primary antibodies: anti-H3
(Abcam ab1791; 1:1,000 dilution), anti- H3.3 (Abnova
H00003021-M01; 1:40), anti-HA (Roche Diagnostics
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GFP (Santa Cruz #SC8334; 1:500), anti-actin (SIGMA;
AC15, 1:5,000).
Additional file
Additional file 1: Figure S1. Level of GFP and HA tagged H3.2 or H3.3
expressed in Xenopus oocyte following mRNA injection. A total of 2 ng of
mRNAs encoding H3.2-HA or H3.3-HA, or 3 ng of H3.2-GFP or H3.3-GFP
mRNAs were injected to the cytoplasm of Xenopus oocyte. Forty-eight
hours after injection proteins were extracted from the oocyte and
subjected to WB analysis. Membranes were probed with antibodies
specific for H3.3, HA, or GFP tags. Memcode staining served as a loading
control. Figure S2. Kinetics of H3.3 deposition into transplanted nuclei. A
time-lapse analysis was performed on H3.2-cherry expressing ESC nuclei
transplanted into H3.3 GFP expressing oocyte germinal vesicles. Twenty-
four hours after H3.3-GFP mRNA injection to the oocyte cytoplasm, the
oocyte germinal vesicle (GV) was isolated in oil. H3.2-cherry ESC nuclei
were then transplanted to these oil-GVs and analyzed by confocal
microscopy for a period of 15 h. Figure S3. qRT-PCR analysis of gene
expression in reporter ESCs with or without retinoic acid differentiation.
ESCs containing an Oct4 reporter (ESC #5) were cultured either in the
presence of LIF or in the absence of LIF and with retinoic acid (1 μM) for
a period of 5 days. Cells were then collected, mRNA extracted, and gene
expression was measured by qRT-PCR. Figure S4. DNA synthesis
independent chromatin assembly on plasmid DNA injected to oocyte is
inhibited by anti-HIRA antibody. In-vivo chromatin assembly assay. We
performed in-vivo chromatin assembly according to Roche et al., Methods
Mol Biol., 129–47, 2006. Circular dsDNA plasmid pBS0 (10 ng) was injected
to Xenopus oocyte germinal vesicle together with 16 nL of water (-),
preimmune serum, or anti-HIRA antibody solutions. DNA synthesis
independent chromatin assembly was then allowed to proceed by
incubating the oocyte for different amount of time (from 15 to 180 min),
after which plasmid DNA was recovered, deproteinized, and analyzed by
electrophoresis. The presence of the anti-HIRA antibody inhibits
chromatin assembly on the injected plasmid, as shown by reduced
supercoiling. Figure S5. Confocal analysis of H3.3 or H3.2 accumulation
onto transplanted chromatin following nuclear transfer to oocytes in
conditions where HIRA is inhibited. Oocytes were preinjected with H3.3-
GFP or H3.2-GFP mRNA. H3.2-cherry expressing ESC #5 nuclei were then
transplanted to the oocyte in the presence of anti-HIRA Antibody or
control Antibody. Forty-eight hours after transplantation, H3.3-GFP (top
panel) or H3.2-GFP (bottom panel) loading onto chromatin was analyzed
by confocal imaging of isolated GVs. Images are Z-stacks projection.
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